XML 101 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-based compensation plans - Company's SARs (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock Appreciation Rights (SARs)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Beginning Balance (in shares) 764,806    
Vested (in shares) 0    
Granted (in shares) 0    
Exercised (in shares) (26,671)    
Forfeited/Expired (in shares) (8,620)    
Ending Balance (in shares) 729,515 764,806  
Exercisable (in shares) 729,515    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]      
Beginning Balance, weighted-average exercise price (usd per share) $ 54.98    
Granted, weighted-average exercise price (usd per share) 0    
Exercised, weighted-average exercise price (usd per share) 49.96    
Forfeited/Expired, weighted average exercise price (usd per share) 0    
Ending Balance, weighted average exercise price (usd per share) 55.13 $ 54.98  
Exercisable, weighted-average exercise price (usd per share) $ 55.13    
Stock Appreciation Rights (SARs) | Nonvested      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Beginning Balance (in shares) 0    
Vested (in shares) 0    
Granted (in shares) 0 0 0
Exercised (in shares) 0    
Forfeited/Expired (in shares) 0    
Ending Balance (in shares) 0 0  
Exercisable (in shares) 0    
Stock Appreciation Rights (SARs) | Vested      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Beginning Balance (in shares) 764,806    
Vested (in shares) 0    
Granted (in shares) 0    
Exercised (in shares) (26,671)    
Forfeited/Expired (in shares) (8,620)    
Ending Balance (in shares) 729,515 764,806  
Exercisable (in shares) 729,515    
Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted (in shares) 205,178    
Performance Contingent Restricted Stock Units (PCSUs) | Nonvested      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted (in shares) 205,178    
Performance Contingent Restricted Stock Units (PCSUs) | Vested      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted (in shares) 0